$RGNX SEC Filings

Filed On	Filing
16 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On October 14, 2026, Kenneth T. Mills resigned from the board of directors (the “Board”) of REGENXBIO Inc. (the “Company”) effective October 21, 2026. Mr. Mills recently became chief executive officer of another company and intends to fo...
13 Oct 2026	SCHEDULE 13G
23 Sep 2026	8-K: Entry into a Material Definitive Agreement On September 23, 2026, REGENXBIO Inc. (the “Company”) and The Trustees of the University of Pennsylvania (“UPenn”) entered into a Settlement Agreement (the “Settlement Agreement”) with Sarepta Therapeutics, Inc. and Sarepta Therapeutics ...
03 Sep 2026	Form 4: Malzahn Craig, Chief Technology Officer Gave up 234 shares to cover exercise price or tax ($2.18K)
03 Sep 2026	Form 4: Chan Mitchell, Chief Financial Officer Gave up 4,902 shares to cover exercise price or tax ($45.7K)
27 Aug 2026	Form 4: Ciongoli Gregory Austin, Director Received 15,432 shares as a grant or award · Granted 69,609 Stock Options (Right to buy) · Bought 49,196 shares ($450K) · 1 more
27 Aug 2026	Form 3: Ciongoli Gregory Austin, Director No securities owned
25 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation
24 Aug 2026	8-K: Regulation FD Disclosure; Other Events
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
04 Aug 2026	Form 4: Pakola Steve, Chief Medical Officer Gave up 7,468 shares to cover exercise price or tax ($72.4K)
04 Aug 2026	Form 4: Christmas Patrick J., Chief Strategy & Legal Officer Gave up 4,699 shares to cover exercise price or tax ($45.5K)
20 Jul 2026	8-K: Other Events
17 Jul 2026	424B5
17 Jul 2026	FWP
16 Jul 2026	424B5
06 Jul 2026	Form 4: Pakola Steve, Chief Medical Officer Received 2,161 shares by exercise or conversion ($17K) · Sold 2,161 shares ($29.5K)
06 Jul 2026	Form 4: Simpson Curran, Director Received 951 shares as a grant or award ($6.65K) · Received 1,453 shares as a grant or award ($14.8K) · Gave up 6,818 shares to cover exercise price or tax ($89.2K)
06 Jul 2026	SC TO-I/A

Comments